Looking for myocardial viability after a STICH trial: Not enough to close the door

Journal of Nuclear Medicine

Volumn 53, Issue 3, 2012, Pages 349-352

  Perrone Filardi, Pasquale ^a   Pinto, Fausto J ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

CORONARY ARTERY BYPASS GRAFT; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL TREATMENT FOR ISCHEMIC HEART FAILURE STUDY; TYPES OF STUDY;

HEART; HUMANS; MYOCARDIAL ISCHEMIA; POSITRON-EMISSION TOMOGRAPHY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84858599919     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.102210     Document Type: Review

References (19)

1. Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol. 2009;53:13-20.
2. Schinkel AF, Bax JJ, Delgado V, Poldermans D, Rahimtoola SH. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction. Am J Med. 2010;123:978-986.
3. Elefteriades JA, Tolis G Jr, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411-1417. (Pubitemid 23316367)
4. Cleland JG, Pennell DJ, Ray SG, et al. Carvedilol hibernating reversible ischaemia trial: marker of success investigators. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet. 2003;362:14-21. (Pubitemid 36840896)
5. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium following revascularization in patients with coronary artery disease. Circulation. 1995;91:2556-2565.
6. Perrone-Filardi P, Pace L, Prastaro M, et al. Assessment of myocardial viability in patients with chronic coronary artery disease: rest-4 hour-24 hour 201thallium tomography vs dobutamine echocardiography. Circulation. 1996;94:2712-2719. (Pubitemid 26411733)
7. Underwood SR, Bax JJ, von Dahl J, et al. Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology. Eur Heart J. 2004;25:815-836. (Pubitemid 38684148)
8. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103-114. (Pubitemid 350301145)
9. Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol. 2006;47:969-977.
10. Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617-1625.
11. Beanlands RS, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging- assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002-2012. (Pubitemid 350054917)
12. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151-1158. (Pubitemid 34267418)
13. European Association for Percutaneous Cardiovascular Interventions, Wijns W, Kolh P, et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010;31:2501-2555.
14. Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607-1616.
15. Pace L, Perrone Filardi P, Mainenti PP, et al. Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium- 201 tomography: optimal image analysis. J Nucl Med. 1998;39:1869-1874. (Pubitemid 28518884)
16. Pace L, Perrone Filardi P, Mainenti PP, et al. Combined evaluation of rest-redistribution thallium-201 tomography and low-dose dobutamine echocardiography enhances the identification of viable myocardium in patients with chronic coronary artery disease. Eur J Nucl Med. 1998;25:744-750. (Pubitemid 28377038)
17. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation. 1995;91:990-998.
18. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing betablocker therapy. Circulation. 2003;108:1945-1953. (Pubitemid 37296539)
19. Pinto FJ. Myocardial viability: the search for a perfect method is not over yet. Eur Heart J. 2000;21:1039-1040. (Pubitemid 30352985)